Related Experiment Video
Updated: Jul 14, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Neutralising antibodies against SARS-CoV-2 give important information on Covid-19 epidemic evolution in Rabat,
Nadia Touil1,2, Charifa Drissi Touzani2, El Mostafa Benaissa3
1Unité de Culture Cellulaire, Centre des Maldies Infectieuses et Tropicales, Hôpital Militaire d'Instruction Mohammed V de Rabat, Morocco.
Background:
The SARS-CoV-2 is an extremely contagious and acute viral disease mainly affecting humans.
Objective:
To estimate seroprevalence of SARS-CoV-2 neutralizing antibodies (NAbs) for illegible armed force individuals living in Rabat, Morocco.
Method:
A convenience sample (N = 2662) was conducted from May 2020 to February 2021. We used the standard neutralization assay to quantify the NAbs titers. A serum was positive when the titer was 1:4. High positive NAbs titers were defined when ≥ 1:32.
Results:
Demographic and socioeconomic status did not affect seroprevalence data. An overall seroprevalence of 24,9% was found. Sera from blood donors, young recruits and auto-immune population had lower NAbs titers. However, titers were above 1:16 in 9% of the population with high risk of SARS-CoV-2 exposure. Seropositivity increased over time with values reaching peaks after the epidemic waves (2.4% in May 2020; 16.2% in August 2020; 22.7% in December 2020 and 37% in February 2021).
Conclusion:
And increase of NAbs was observed over time and correlated with the post-epidemic waves of COVID-19 in Morocco.
More Related Videos
Related Concept Videos
Cross-reactivity
Coronavirus
Respiratory Syncytial Virus Disease

